Generic Drugs Market Reports

Find the information you need on generic drugs. The Kalorama Information collection of research reports provides insights into product trends, analyses, opportunities, projections, and sales and marketing strategies. Specifics on market share, size, and growth in US and global generics markets are also featured.

Title	Published	Price
The World Market for Biosimilars and the Potential for US Follow-on Biologics Biosimilars, or generic biologic drugs, are marketed around the world but still restricted in the U.S. This may soon change, and Kalorama Information has released this timely study of the market in Europe and other areas in the world and the possibility of a U.S. Market in the near  |  more... Search inside this report	Aug 1, 2009	$3,700.00
Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics) Current economic conditions dominate business strategies. While healthcare has fared better than other industries, it will not be immune from the effects of the current recession. But what aspects of healthcare will be impacted? How much of spending will be out of the consumer's pocket? How  |  more... Search inside this report	Apr 1, 2009	$1,995.00
Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE) At present the Middle East region constitutes as small percent of global pharmaceutical sales. However, ever-increasing populations and governmental healthcare reforms are likely to increase demand. These markets will be essential for pharmaceuticals companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for  |  more... Search inside this report	Nov 1, 2008	$3,300.00
The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends) Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treatments.  |  more... Buy by the section | Search inside this report	Aug 1, 2008	$2,995.00
World Market for Prescription Generic Drugs, 6th Edition Generics, so long the force that has shaken up the branded pharmaceutical industry, is now facing its own challenges as an industry. While growth indications are strong, there are challenges for generic companies. In the next two years, consolidation will most likely rise; the sector is expected to  |  more... Search inside this report	Apr 1, 2008	$3,995.00
Biogenerics: The World Market for Biosimilars In one sense, the opportunity for follow-on proteins is as good as ever. Some of the biggest-selling biologics developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, have lost patent protection or are set to lose patent protection  |  more... Search inside this report	Apr 1, 2008	$3,500.00
Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches, Retail Clinics, Prescribing Pharmacists, The Growing Out of Pocket Healthcare Market) Pharmaceutical marketers will face a challenging time in 2008 by all reports. Understanding the dynamics of the market can assist in better planning and strategy. This Kalorama Information Report Bundle combines 5 of the most important topics for those in the pharmaceutical industry in a strategic planning, business  |  more... Search inside this report	Mar 15, 2008	$6,995.00
The World Market for Prescription Generic Drugs, 5th Edition The landscape of generic companies is changing: their relative might in the industry is increasing and the product lines their offering are growing in depth and breadth. Strong growth in the sector has come not only from more aggressive tactics and better acceptance in the clinical and consumer population, but  |  more... Buy by the section | Search inside this report	Apr 1, 2006	$3,500.00
The Market for Generic Biologics: Issues, Trends, and Market Potential, 2nd edition Some of the biggest-selling biological drugs developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, are set to lose patent protection in the United States in 2005 and soon after. This opens up a market currently worth over $30 billion  |  more... Buy by the section | Search inside this report	Nov 1, 2005	$2,500.00
Markets in Geriatric Medicine: 45+ Market in the United States, Volumes I - III Markets in Geriatric Medicine is a collection of reports that address the technologies and markets associated with age-related disorders and diseases. As the American population ages, with the “Baby Boom” generation approaching the age of retirement and Medicare benefits, the incidence and prevalence of age-related disorders is expected to  |  more...	Mar 1, 2004	$7,200.00
Marketlooks: Prescription Generic Central Nervous System and Psychotherapeutic Drugs MarketLooks, from MarketResearch.com, are concise 15-30 page summaries of popular full-length market research reports published by Kalorama Information. This MarketLooks report has been compiled from the following full-length study: Title: The Worldwide Market for Prescription Generic Drugs- 4th Ed. published in November 2002  |  more... Search inside this report	Nov 1, 2002	$399.00
Marketlooks: Prescription Generic Cardiovascular Drugs MarketLooks, from MarketResearch.com, are concise 15-30 page summaries of popular full-length market research reports published by Kalorama Information. This MarketLooks report has been compiled from the following full-length study: Title: The Worldwide Market for Prescription Generic Drugs- 4th Ed. published in November 2002  |  more... Search inside this report	Nov 1, 2002	$399.00
The Worldwide Market for Prescription Generic Drugs- 4th Edition The worldwide prescription generic drug market has evolved into a formidable and important participant in the complex world of healthcare. Generic drug manufacturers are poised for strong growth in the future as patent protection for a host of major pharmaceuticals are due to expire and new legislative reforms in the  |  more... Buy by the section | Search inside this report	Nov 1, 2002	$3,500.00
The Market for Prescription Generic Drugs This report covers the generic drugs industry in the United States and presents all major therapeutic categories for generic drugs between 1995 and 2004. The report analyzes the issues affecting the market, including an assessment of the FDA relationship with the generics industry, generic drug development and performance  |  more... Buy by the section | Search inside this report	Apr 1, 2000	$2,112.00
MarketLooks: The U.S. Market for Prescription Generic Drugs MarketLooks are concise, graphic-rich summaries of full-length market research reports. Reports that cover more than one market segment are split into corresponding MarketLooks to allow you to purchase only what you need. All MarketLooks are created in PowerPoint(R) for easy extraction of text, charts and tables for use in  |  more...	Apr 1, 2000	$399.00
The Market for Generic Drugs This Kalorama Information report focuses on major product categories, including cardiovascular, analgesic, central nervous system, gastrointestinal, anti-infective and cancer drugs. Updated to include the most pressing issues and trends facing the generic industry—GATT legislation, patent changes, industry consolidation, managed care and mandatory Substitution—the report provides revenue data for  |  more... Buy by the section | Search inside this report	Jul 1, 1998	$2,437.50
Geriatric Drugs And Disease Management This report, published by Kalorama Information, provides important insight for tapping the huge potential of geriatric disease therapy market. Discusses alternatives to drug therapy in geriatric disease management, including radiation therapy and surgery for cancer treatment, angioplasty and diet modifications for cardiovascular disease, and fetal cell transplation and surgery for  |  more... Search inside this report	Aug 1, 1995	$1,625.00
Title	Published	Price